BioLife Solutions Inc (BLFS)

Fixed asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	102,868	122,972	125,729	136,909	142,796	154,008	161,427	162,452	161,032	154,468	147,521	138,192	118,837	96,581	74,057	52,773	48,087	41,249	36,673	33,590
Property, plant and equipment	US$ in thousands	6,084	17,709	17,256	21,042	5,689	20,998	25,565	26,100	23,638	21,737	19,117	18,259	17,657	17,462	16,450	11,231	10,120	5,300	5,347	5,407
Fixed asset turnover		16.91	6.94	7.29	6.51	25.10	7.33	6.31	6.22	6.81	7.11	7.72	7.57	6.73	5.53	4.50	4.70	4.75	7.78	6.86	6.21

December 31, 2024 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $102,868K ÷ $6,084K
= 16.91

BioLife Solutions Inc's fixed asset turnover has shown some fluctuations over the period covered in the data. The ratio has ranged from a low of 4.50 in June 2021 to a high of 25.10 in December 2023, indicating variability in the efficiency with which the company is generating revenue from its fixed assets.

Overall, the trend in fixed asset turnover appears to be relatively stable, with some peaks and troughs along the way. The ratio generally ranges between 4.50 and 7.72, with occasional outliers such as the high value of 25.10 in December 2023. This outlier may warrant further investigation to understand the significant increase in fixed asset turnover during that period.

It is important to note that a higher fixed asset turnover generally indicates that the company is effectively utilizing its fixed assets to generate sales. However, a very high ratio, such as seen in December 2023, could suggest potential issues like overvaluation of assets or fluctuations in sales that may need to be explored.

In conclusion, while BioLife Solutions Inc's fixed asset turnover has shown some fluctuations, the company seems to generally maintain a reasonable level of efficiency in generating revenue from its fixed assets. Potential anomalies, such as the exceptionally high ratio in December 2023, may require further analysis to understand the underlying factors driving such fluctuations.